These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37347503)

  • 1. The lufaxin inhibitor caught in the act.
    Andersen GR
    Blood; 2023 Jun; 141(25):3017-3018. PubMed ID: 37347503
    [No Abstract]   [Full Text] [Related]  

  • 2. A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism.
    Andersen JF; Lei H; Strayer EC; Kanai T; Pham V; Pan XZ; Alvarenga PH; Gerber GF; Asojo OA; Francischetti IMB; Brodsky RA; Valenzuela JG; Ribeiro JMC
    Blood; 2023 Jun; 141(25):3109-3121. PubMed ID: 36947859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.
    Collin N; Assumpção TC; Mizurini DM; Gilmore DC; Dutra-Oliveira A; Kotsyfakis M; Sá-Nunes A; Teixeira C; Ribeiro JM; Monteiro RQ; Valenzuela JG; Francischetti IM
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2185-98. PubMed ID: 22796577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sand Fly Salivary Protein Lufaxin Inhibits the Early Steps of the Alternative Pathway of Complement by Direct Binding to the Proconvertase C3b-B.
    Mendes-Sousa AF; do Vale VF; Silva NCS; Guimaraes-Costa AB; Pereira MH; Sant'Anna MRV; Oliveira F; Kamhawi S; Ribeiro JMC; Andersen JF; Valenzuela JG; Araujo RN
    Front Immunol; 2017; 8():1065. PubMed ID: 28912782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on phospholipids in the action of a lupus coagulation inhibitor.
    Exner T; Rickard KA; Kronenberg H
    Pathology; 1975 Oct; 7(4):319-28. PubMed ID: 1223721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The "activated coagulation time (ACT)": two simple screening methods for evaluating coagulation disorders in dogs].
    Glaus T; Hudak-Glaus D; Hoeptner C; Arnold P; Lutz H
    Schweiz Arch Tierheilkd; 1996; 138(11):532-6. PubMed ID: 9026910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
    Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
    Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and immunity: Caught in the fibrin web.
    Sozmen EG; Akassoglou K
    Immunity; 2021 Nov; 54(11):2439-2441. PubMed ID: 34758333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the blood coagulation system induced by bacterial endotoxins. II. In vitro.
    McKAY DG; SHAPIRO SS; SHANBERGE JN
    J Exp Med; 1958 Mar; 107(3):369-76. PubMed ID: 13513906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
    Hoffmann C; Amiral J; Rezig S; Kerspern H; Jantzem H; Robin S; Collins A; Mornet C; Mingant F; Pan Petesch B; Ianotto JC; Lippert E; Galinat H
    Eur J Haematol; 2019 Aug; 103(2):137-139. PubMed ID: 31102471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupivacaine inhibits whole blood coagulation in vitro.
    Kohrs R; Hoenemann CW; Feirer N; Durieux ME
    Reg Anesth Pain Med; 1999; 24(4):326-30. PubMed ID: 10445771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonoclot evaluation of whole blood coagulation in healthy adult dogs.
    Babski DM; Brainard BM; Krimer PM; Ralph AG; Pittman JR; Koenig A
    J Vet Emerg Crit Care (San Antonio); 2012 Dec; 22(6):646-52. PubMed ID: 23216839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does warfarin affect the activated coagulation time?
    Chang RJ; Doherty TM; Goldberg SL
    Am Heart J; 1998 Sep; 136(3):477-9. PubMed ID: 9736140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The storage lesion of packed red blood cells affects coagulation.
    Aucar JA; Sheth M
    Surgery; 2012 Oct; 152(4):697-702; discussion 702-3. PubMed ID: 22939747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A NORMAL INHIBITOR OF THE BLOOD COAGULATION CONTACT REACTION PRODUCT.
    NOSSEL HL; NIEMETZ J
    Blood; 1965 May; 25():712-23. PubMed ID: 14282040
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood coagulation and fibrinolysis after long-duration treadmill exercise controlled by individual anaerobic threshold.
    Hilberg T; Gläser D; Reckhart C; Prasa D; Stürzebecher J; Gabriel HH
    Eur J Appl Physiol; 2003 Nov; 90(5-6):639-42. PubMed ID: 12883904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated coagulation times in normal cats and dogs using MAX-ACT tubes.
    See AM; Swindells KL; Sharman MJ; Haack KL; Goodman D; Delaporta A; Robertson I; Foster SF
    Aust Vet J; 2009 Jul; 87(7):292-5. PubMed ID: 19573157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.